首页> 外文OA文献 >Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma ERMETIC Project—Part 1)

【2h】

Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma ERMETIC Project—Part 1)

机译：表皮生长因子受体和KRAS突变检测在74个非小细胞肺癌非盲样品中的交叉验证研究：由15个法国分子实验室对总计5550个外显子进行了测序（EGFR突变状态用于评估EGFR-TKIs的评估）非小细胞肺癌ERMETIC项目-第1部分）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Beau-Faller Michèle; Degeorges Armelle; Rolland Estelle; Mounawar Mounia; Antoine Martine; Poulot Virginie; Mauguen Audrey; Barbu Véronique; Coulet Florence; Prétet Jean-Luc; Bièche Ivan; Blons Hélène; Boyer Jean-Christophe; Buisine Marie-Pierre; de Fraipont Florence; Lizard Sarab; Olschwang Sylviane; Saulnier Patrick; Prunier-Mirebeau Delphine; Richard Nicolas; Danel Claire; Brambilla Elisabeth; Chouaid Christos; Zalcman Gérard; Hainaut Pierre; Michiels Stefan; Cadranel Jacques;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma (ERMETIC) Project-Part 1). [J] . Beau Faller M, Rolland E, Antoine M, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2011,第6期

机译：表皮生长因子受体和KRAS突变检测在74个非小细胞肺癌非盲样品中的交叉验证研究：由15个法国分子实验室对总计5550个外显子进行测序（EGFR突变状态在EGFR-TKIs管理中的评估）非小细胞肺癌（ERMETIC）项目-第1部分）。
2. A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting - IFCT/ERMETIC2 project part 1: Comparison of testing methods in 20 french molecular genetic national cancer institute platforms [J] . Beau-FallerM., BlonsH., DomergC., The Journal of molecular diagnostics: JMD . 2014,第1期

机译：在临床非小细胞肺癌环境中评估EGFR和KRAS突变检测方法的多中心盲研究-IFCT / ERMETIC2项目第1部分：20个法国分子遗传学国家癌症研究所平台中检测方法的比较
3. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J] . Wen Gao, Jing He, Shi-Dai Jin, OncoTargets and therapy . 2019,第2期

机译：初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制作用的抗T790M突变抗性抗性抗性抗肺癌患者的抗性抗性，抗血疱剂血管生长因子受体酪氨酸激酶激酶抑制剂
4. Design, Construction, and Verification of a LATE-PCR and Lights-On/Lights-Off Probe Assay for Mutation Detection in Exons 18-21 of the EGFR Gene: Implications for Molecular Diagnosis of Non-Small Cell Lung Carcinoma [D] . Tetrault, Shana Augustin 2012

机译：用于EGFR基因外显子18-21突变检测的LATE-PCR和开/关灯探针检测的设计，构建和验证：对非小细胞肺癌的分子诊断意义
5. Evaluation of epidermal growth factor receptor mutations and thyroid transcription factor-1 status in Turkish non-small cell lung carcinoma patients: A study of 600 cases from a single center [O] . Malahat Musayeva, Serpil Dizbay Sak, Hilal Özakıncı, 2020

机译：土耳其非小细胞肺癌患者表皮生长因子受体突变和甲状腺转录因子-1状态的评估：来自单个中心的600例研究
6. Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Lung Carcinoma [ERMETIC] Project-Part 1). [O] . Beau-Faller, Michèle, Degeorges, Armelle, Rolland, Estelle, 2011

机译：表皮生长因子受体和KRAS突变检测在74个非小细胞肺癌非盲样品中的交叉验证研究：由15个法国分子实验室对总计5550个外显子进行了测序（EGFR突变状态在EGFR-TKIs管理中的评估）非小肺癌[ERMETIC]项目第1部分）。

著录项

引文网络

相似文献

相关主题

期刊订阅